Dario Neri

ETH Zurich Wolfgang Pauli Str. 10
Zurich, ZH 8093, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 305 publications

Neoadjuvant Intralesional Daromun (L19IL2/L19TNF) in Resectable Locally Advanced Melanoma: An Update on the Efficacy and Safety Results of the PIVOTAL Phase III Trial.

Neoadjuvant Intralesional Daromun (L19IL2/L19TNF) in Resectable Locally Advanced Melanoma: An Update on the Efficacy and Safety Results of the PIVOTAL Phase III Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: August 11, 2026

Leveraging Clinical Trials in Client-Owned Pets to Accelerate Drug Development for Human Patients.

Leveraging Clinical Trials in Client-Owned Pets to Accelerate Drug Development for Human Patients.

Journal: Journal of medicinal chemistry

Published: June 25, 2026

From DNA-Encoded Chemistry to Tumor-Targeted Small Molecule Therapeutics.

From DNA-Encoded Chemistry to Tumor-Targeted Small Molecule Therapeutics.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: June 25, 2026

High-Throughput Binding Kinetic Measurements of DNA-Encoded Library-Derived Hits By Focal Molography.

High-Throughput Binding Kinetic Measurements of DNA-Encoded Library-Derived Hits By Focal Molography.

Journal: Journal of medicinal chemistry

Published: June 16, 2026

A Small-Molecule Drug Conjugate Targeting FAP Exhibits Potent Activity in Dogs with Spontaneous Tumors.

A Small-Molecule Drug Conjugate Targeting FAP Exhibits Potent Activity in Dogs with Spontaneous Tumors.

Journal: Journal of medicinal chemistry

Published: May 16, 2026

A fluorescein-conjugated somatostatin receptor antagonist adapter for chimeric antigen receptor T cell therapy of meningioma.

A fluorescein-conjugated somatostatin receptor antagonist adapter for chimeric antigen receptor T cell therapy of meningioma.

Journal: Neuro-oncology advances

Published: March 17, 2026

Combination with Immunocytokines Enhances the Anticancer Activity of Small Molecule Drug Conjugates and Radioligand Therapeutics Targeting Fibroblast Activation Protein.

Combination with Immunocytokines Enhances the Anticancer Activity of Small Molecule Drug Conjugates and Radioligand Therapeutics Targeting Fibroblast Activation Protein.

Journal: Molecular pharmaceutics

Published: February 13, 2026

Dynamics, Pharmacokinetics, and Dosimetry of First-in-Human [68Ga]Ga-OncoACP3-DOTA PET in Patients with Prostate Cancer.

Dynamics, Pharmacokinetics, and Dosimetry of First-in-Human [68Ga]Ga-OncoACP3-DOTA PET in Patients with Prostate Cancer.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: December 19, 2025

Targeted TNF Potentiates the Activity of Bispecific T-cell Engagers in Solid Tumors by Turning Cold Tumors Hot.

Targeted TNF Potentiates the Activity of Bispecific T-cell Engagers in Solid Tumors by Turning Cold Tumors Hot.

Journal: Cancer immunology research

Published: December 09, 2025

Imaging-guided optimization of biodistribution and antitumor efficacy of L19-based immunocytokines.

Imaging-guided optimization of biodistribution and antitumor efficacy of L19-based immunocytokines.

Journal: Translational oncology

Published: November 17, 2025

Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia.

Enhancement of CD117-Targeted Bispecific T-cell Engagement by CD33-Targeted Bispecific T-cell Costimulation in Acute Myeloid Leukemia.

Journal: Cancer research communications

Published: November 02, 2025

Quantitative Mass Spectrometry-Based Biodistribution of Monoclonal Antibodies: An Alternative to Radio-Biodistribution.

Quantitative Mass Spectrometry-Based Biodistribution of Monoclonal Antibodies: An Alternative to Radio-Biodistribution.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: October 22, 2025

Showing 1-12 of 305

Last Updated: 09/26/2026